TrialReader


Evaluation of Gut Microbiome in Patients With Prostate Cancer

NCT03709485 — Not applicable, Unknown, 150 participants, Ziv Hospital

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Analysis of Gut Microbiome in Prostate Cancer Patients

RegistryNCT03709485
StatusUnknown
PhaseNot applicable
Study typeInterventional; na, single group, masking: none, basic science
Enrollment150 (Estimated)
SponsorZiv Hospital (Other gov)
ConditionsProstate Cancer
Interventionsrectal swab for microbial culture. (Other)
Datesstart 2018-11-01 (estimated), primary completion 2019-11-01 (estimated), completion 2019-12-30 (estimated), first posted 2018-10-17, last updated 2018-10-17

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Prostate Cancer All trials of rectal swab for microbial culture.

-Summary

The research will focus on the possible connection between prostate cancer, and various species of bacteria in the large intestine. In consecutive patients, referred to prostate biopsies, rectal swabs will be taken before the biopsies and before antibiotic treatment. The gut flora will be examined and characterized by a microbiome analysis tool. Negative patients will serve as internal control. The investigators will look for association between prostate cancer of various grades and the presence of specific enteropathogens in the rectal flora of the participants.

Expand all sections  ·  Collapse all

+Detailed description

Prostate cancer is the no. 1 cancer among men. Risk factors include Afro-American origin, prostate cancer in a first degree relatives and the presence of BRCA2 genetic mutations. No specific association has been described yet between prostate cancer and specific gut bacteria.

The GI tract is the home of billions of bacteria. The microbiome functions as a separate organ and contains 10 times the amount of genes compared to the human genome. The microbiome has crucial impact on the human metabolism, inflammatory processes and filtration of GI content. All of these effects may contribute to the exposure of the human body to various carcinogens and inflammatory factors, leading eventually to the development of cancer in remote organs.

The purpose of this research is to try and identify specific species that might be related to the development of prostate cancer.

+Arms and interventions

ArmTypeInterventionsDescription
prostate biopsy patientsExperimentalOther: rectal swab for microbial culture.a cohort o consecutive patients referred to prostate biopsies. In all patients, a rectal swab will be taken prior to biopsy and antimicrobial treatment. The swab will be cultured and analyzed in the lab for characterization of the microbiome.
  • rectal swab for microbial culture. (Other): Rectal swab and culture.

+Outcome measures

Primary outcomes

  • Characterization of gut microbiome [1 year]: Analysis of rectal swab cultures.
  • Association of prostate cancer patients and specific microbes. [1 year]: Relationship between patients with prostate cancer and specific strains of rectal microbes

+Eligibility

Sex: Male, ages: 45 Years to any

Inclusion Criteria:

* male gender
* age above 45
* referred for prostate biopsy

Exclusion Criteria:

* age below 45
* antimicrobial therapy in the 7 days prior to biopsy
* previous prostate or pelvic irradiation
* patients who suffer from inflammatory bowel disease
* systemic chemotherapy for any reason in the 3 months prior to the biopsy.

+Publications

  • Liss MA, White JR, Goros M, Gelfond J, Leach R, Johnson-Pais T, Lai Z, Rourke E, Basler J, Ankerst D, Shah DP. Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate Cancer. Eur Urol. 2018 Nov;74(5):575-582. doi: 10.1016/j.eururo.2018.06.033. Epub 2018 Jul 12. PMID 30007819
  • Golombos DM, Ayangbesan A, O'Malley P, Lewicki P, Barlow L, Barbieri CE, Chan C, DuLong C, Abu-Ali G, Huttenhower C, Scherr DS. The Role of Gut Microbiome in the Pathogenesis of Prostate Cancer: A Prospective, Pilot Study. Urology. 2018 Jan;111:122-128. doi: 10.1016/j.urology.2017.08.039. Epub 2017 Sep 6. PMID 28888753
  • Porter CM, Shrestha E, Peiffer LB, Sfanos KS. The microbiome in prostate inflammation and prostate cancer. Prostate Cancer Prostatic Dis. 2018 Sep;21(3):345-354. doi: 10.1038/s41391-018-0041-1. Epub 2018 May 23. PMID 29795140

My Notes